HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AN-1792

a synthetic 42-amino acid form of naturing occurring amyloid beta42 peptide, primary component of the beta-amyloid plaques; in phase I clinical trial (10/2001)
Also Known As:
AN1792
Networked: 49 relevant articles (8 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Imbimbo, Bruno P: 4 articles (03/2014 - 11/2010)
2. Solfrizzi, Vincenzo: 4 articles (03/2014 - 11/2010)
3. Panza, Francesco: 4 articles (03/2014 - 11/2010)
4. Tabira, Takeshi: 4 articles (11/2011 - 11/2009)
5. Cribbs, David H: 4 articles (04/2010 - 02/2005)
6. Logroscino, Giancarlo: 3 articles (03/2014 - 12/2011)
7. Holmes, Clive: 3 articles (09/2013 - 04/2003)
8. Nicoll, James A R: 3 articles (09/2013 - 04/2003)
9. Pilotto, Alberto: 3 articles (02/2012 - 11/2010)
10. Seripa, Davide: 3 articles (02/2012 - 11/2010)

Related Diseases

1. Amyloid Plaque
2. Meningoencephalitis
3. Alzheimer Disease (Alzheimer's Disease)
4. Dementia (Dementias)
5. Encephalitis (Encephalitis, Rasmussen)

Related Drugs and Biologics

1. Amyloid (Amyloid Fibrils)
2. Amyloid beta-Peptides
3. tebufenozide (Mimic)
4. Antibodies
5. Epitopes
6. Scavenger Receptors (Scavenger Receptor)
7. Complement C1q (C1q Complement)
8. Vaccines
9. Immunoglobulins (Immunoglobulin)
10. Immunoglobulin G (IgG)

Related Therapies and Procedures

1. Immunotherapy